Popular Pharmaceuticals Limited
Md. Mahmudul Hasan is an experienced professional in the field of Quality Assurance, currently serving as a Senior Executive at Popular Pharmaceuticals Limited since June 2025. Previously, Md. Mahmudul Hasan held the position of Assistant Quality Assurance Manager at Renata PLC from March 2024 to June 2025, where responsibilities included PDE assessment and cleaning validation studies. Prior to that, Md. Mahmudul Hasan worked at Everest Pharmaceuticals Ltd. from October 2018 to February 2024, progressing from Senior Quality Assurance Officer to Senior Executive and Quality Assurance Executive. Md. Mahmudul Hasan holds a Master's degree in Pharmacy and a Bachelor's degree in Pharmacy, both from Daffodil International University.
This person is not in any teams
This person is not in any offices
Popular Pharmaceuticals Limited
The State of the Art manufacturing facilities of Popular Pharmaceuticals Ltd. (PPL), is located in an industrial area close to the International Airport of the capital city, Dhaka. The total land area of this site is 22,952 m2 with a covered area of 13,509 m2. The manufacturing site is built with strict compliance to WHO cGMP standards and also to meet US FDA and UK MHRA requirements. The project involved an investment of BDT 2,000 M (US$ 30 M approx.); the ever highest initial investment for a pharmaceutical plant in Bangladesh.Through captivating marketing strategies coupled with optimum productivity across all its activities with quality People, Plant and Product, PPL is committed to deliver top tier performance round the year. PPL is continuously investing in diversifying the ranges of products and services to complement the aura with all the major therapeutic areas. PPL aims to create enduring value for the society, and deliver a sustained financial performance that will match the best in the industry. Popular Pharmaceuticals Ltd. intends to focus its skills and resources on all major therapeutic areas that represent majority of the burden of disease profiles of Bangladesh. Popular Pharmaceuticals Ltd. is also committed to delivering new, medically important and commercially successful products to the market every year. Along with its commitment to competitiveness and high performance, PPL will continue to be led by its core values to achieve sustainable success. Efficient pharmaceutical business requires transparent, quality assured processes which are acceptable to regulatory authorities worldwide in addition to the use of complementary new technologies. PPL is committed to the best use of available technology and expertise of the time and thereby ensuring continuous improvements with regards to effectiveness and efficiency.